The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARGENX SE | SPONSORED ADR | 04016X101 | 121,800,429 | 131,283 | SH | SOLE | 131,283 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 40,465,250 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| DISC MEDICINE INC | COM | 254604101 | 17,562,743 | 240,125 | SH | SOLE | 240,125 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 76,850,910 | 410,353 | SH | SOLE | 410,353 | 0 | 0 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 131,681,580 | 1,186,000 | SH | SOLE | 1,186,000 | 0 | 0 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 1,398,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||